Issue navigation
Volume 6, Issue 3, September 2024
Editorial
Editorial: Translational control in cancer
Francesca Aguilo and Erik Dassi
NAR Cancer, Volume 6, Issue 3, September 2024, zcae031, https://doi.org/10.1093/narcan/zcae031
Critical Reviews and Perspectives
Ribosome specialization in cancer: a spotlight on ribosomal proteins
Sofia Ramalho and others
NAR Cancer, Volume 6, Issue 3, September 2024, zcae029, https://doi.org/10.1093/narcan/zcae029
Decoding ribosome complexity: role of ribosomal proteins in cancer and disease
Pedro Fuentes and others
NAR Cancer, Volume 6, Issue 3, September 2024, zcae032, https://doi.org/10.1093/narcan/zcae032
Novel insights into the role of bisphenol A (BPA) in genomic instability
Anastasia Hale and George-Lucian Moldovan
NAR Cancer, Volume 6, Issue 3, September 2024, zcae038, https://doi.org/10.1093/narcan/zcae038
Decoding the molecular symphony: interactions between the m6A and p53 signaling pathways in cancer
Rachel Shoemaker and others
NAR Cancer, Volume 6, Issue 3, September 2024, zcae037, https://doi.org/10.1093/narcan/zcae037
Cancer Computational Biology
CytoCellDB: a comprehensive resource for exploring extrachromosomal DNA in cancer cell lines
Jacob Fessler and others
NAR Cancer, Volume 6, Issue 3, September 2024, zcae035, https://doi.org/10.1093/narcan/zcae035
Cancer Gene Regulation, Chromatin, and Epigenetics
High-level tumour methylation of BRCA1 and RAD51C is required for homologous recombination deficiency in solid cancers
Lijun Xu and others
NAR Cancer, Volume 6, Issue 3, September 2024, zcae033, https://doi.org/10.1093/narcan/zcae033
DNA Damage Sensing and Repair
Intrinsic PARG inhibitor sensitivity is mimicked by TIMELESS haploinsufficiency and rescued by nucleoside supplementation
Camilla Coulson-Gilmer and others
NAR Cancer, Volume 6, Issue 3, September 2024, zcae030, https://doi.org/10.1093/narcan/zcae030
DNA abasic sites act as rational therapeutic targets to synergize temozolomide response in both MMR-proficient and deficient cancer
Achyut Bora and others
NAR Cancer, Volume 6, Issue 3, September 2024, zcae034, https://doi.org/10.1093/narcan/zcae034
Correction
Correction to ‘Ku–DNA binding inhibitors modulate the DNA damage response in response to DNA double-strand breaks’
NAR Cancer, Volume 6, Issue 3, September 2024, zcae036, https://doi.org/10.1093/narcan/zcae036
Advertisement
Advertisement